Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
1.
Front Oncol ; 12: 1045016, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36439420

RESUMEN

Total body irradiation (TBI) is a commonly used conditioning regimen for hematopoietic stem cell transplant (HCT), but dose heterogeneity and long-term organ toxicity pose significant challenges. Total marrow irradiation (TMI), an evolving radiation conditioning regimen for HCT can overcome the limitations of TBI by delivering the prescribed dose targeted to the bone marrow (BM) while sparing organs at risk. Recently, our group demonstrated that TMI up to 20 Gy in relapsed/refractory AML patients was feasible and efficacious, significantly improving 2-year overall survival compared to the standard treatment. Whether such dose escalation is feasible in elderly patients, and how the organ toxicity profile changes when switching to TMI in patients of all ages are critical questions that need to be addressed. We used our recently developed 3D image-guided preclinical TMI model and evaluated the radiation damage and its repair in key dose-limiting organs in young (~8 weeks) and old (~90 weeks) mice undergoing congenic bone marrow transplant (BMT). Engraftment was similar in both TMI and TBI-treated young and old mice. Dose escalation using TMI (12 to 16 Gy in two fractions) was well tolerated in mice of both age groups (90% survival ~12 Weeks post-BMT). In contrast, TBI at the higher dose of 16 Gy was particularly lethal in younger mice (0% survival ~2 weeks post-BMT) while old mice showed much more tolerance (75% survival ~13 weeks post-BMT) suggesting higher radio-resistance in aged organs. Histopathology confirmed worse acute and chronic organ damage in mice treated with TBI than TMI. As the damage was alleviated, the repair processes were augmented in the TMI-treated mice over TBI as measured by average villus height and a reduced ratio of relative mRNA levels of amphiregulin/epidermal growth factor (areg/egf). These findings suggest that organ sparing using TMI does not limit donor engraftment but significantly reduces normal tissue damage and preserves repair capacity with the potential for dose escalation in elderly patients.

2.
Plant Physiol Biochem ; 54: 27-33, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22369938

RESUMEN

Calcium-dependent protein kinases (CPKs) constitute a unique family of kinases involved in many physiological responses in plants. Biochemical and kinetic properties of a recombinant Swainsona canescens calcium-dependent protein kinase (ScCPK1) were examined in this study. The optimum pH and temperature for activity were pH 7.5 and 37 °C, respectively. Substrate phosphorylation activity of ScCPK1 was calmodulin (CaM) independent. Yet CaM antagonists, W7 [N-(6-aminohexyl)-5-chloro-1-naphthalene sulphonamide] and calmidazolium inhibited the activity with IC(50) values of 750 nM and 350 µM, respectively. Both serine and threonine residues were found to be phosphorylated in autophosphorylated ScCPK1 and in histone III-S phosphorylated by ScCPK1. The [Ca(2)(+)] for half maximal activity (K(0.5)) was found to be 0.4 µM for ScCPK1 with histone III-S as substrate. Kinetic analysis showed that K(M) of ScCPK1 for histone III-S was 4.8 µM. These data suggest that ScCPK1 is a functional Ser/Thr kinase, regulated by calcium, and may have a role in Ca(2)(+)-mediated signaling in S. canescens.


Asunto(s)
Calcio/metabolismo , Calmodulina/metabolismo , Fabaceae/enzimología , Proteínas de Plantas/metabolismo , Proteínas Quinasas/metabolismo , Serina/metabolismo , Treonina/metabolismo , Calmodulina/antagonistas & inhibidores , Inhibidores Enzimáticos/farmacología , Fabaceae/metabolismo , Histonas/metabolismo , Concentración de Iones de Hidrógeno , Imidazoles/farmacología , Fosforilación , Proteínas Recombinantes/metabolismo , Transducción de Señal , Sulfonamidas/farmacología , Temperatura
3.
Indian J Microbiol ; 51(3): 326-31, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22754011

RESUMEN

Superoxide dismutase has been discovered within the periplasm of several Gram-negative pathogens. We studied the Cu,Zn-SOD enzyme in Escherichia coli isolated from clinical samples (stool samples) collected from patients suffering from diarrhea. Antibiogram studies of the isolates were carried out to determine the sensitive and resistant strains. The metal co-factor present in the enzyme was confirmed by running samples in native gels and inhibiting with 2 mM potassium cyanide. A 519 bp sodC gene was amplified from resistant and sensitive strains of Escherichia coli. Cloning and sequencing of the sodC gene indicated variation in the protein and amino acid sequences of sensitive and resistant isolates. The presence of sodC in highly resistant Escherichia coli isolates from diarrheal patients indicates that sodC may play role in enhancing the pathogenicity by protecting cells from exogenous sources of superoxide, such as the oxidative burst of phagocytes. The presence of SodC could be one of the factors for bacterial virulence.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA